Efficacy of lenalidomide in high-risk diffuse large B-cell lymphoma

Br J Haematol. 2020 Feb;188(4):e33-e36. doi: 10.1111/bjh.16302. Epub 2019 Dec 17.

Affiliations

¹ Wilmot Cancer Institute, University of Rochester, Rochester, NY, USA.
² Department of Pathology, University of Rochester, Rochester, NY, USA.

PMID: 31845324
DOI: 10.1111/bjh.16302

No abstract available

Publication types

Letter

MeSH terms

Aged
Disease-Free Survival
Female
Follow-Up Studies
Humans
Lenalidomide / administration & dosage*
Lymphoma, Large B-Cell, Diffuse / drug therapy*
Lymphoma, Large B-Cell, Diffuse / mortality*
Male
Middle Aged
Risk Factors
Survival Rate

Substances

Lenalidomide